CN Patent

CN112262218B — 用于单细胞处理中的质量控制的系统和方法

Assigned to 10X Genomics Inc · Expires 2024-11-08 · 2y expired

What this patent protects

提供了用于分析单细胞应用或实验的系统和方法。一组对照珠粒可被引入生物样品并进行所述单细胞应用。所述对照珠粒可被构造为模拟所述生物样品中的分析物，例如细胞或其它分析物，并包括一个或多个已知序列。可鉴定所述一个或多个已知序列以分析所述单细胞应用。

USPTO Abstract

提供了用于分析单细胞应用或实验的系统和方法。一组对照珠粒可被引入生物样品并进行所述单细胞应用。所述对照珠粒可被构造为模拟所述生物样品中的分析物，例如细胞或其它分析物，并包括一个或多个已知序列。可鉴定所述一个或多个已知序列以分析所述单细胞应用。

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN112262218B
Jurisdiction: CN
Classification: —
Expires: 2024-11-08
Drug substance claim: No
Drug product claim: No
Assignee: 10X Genomics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.